Pharmaceutical nanoparticles and the mucin biopolymer barrier

BioImpacts

Volumn 2, Issue 4, 2012, Pages 173-174

  Aljayyoussi, Ghaith ^a   Abdulkareem, Muthanna ^a   Griffiths, Peter ^b   Gumbleton, Mark ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Mucin; Mucus; Nanoparticles

Indexed keywords

BIOPOLYMER; MUCIN; NANOPARTICLE;

ARTICLE; BINDING AFFINITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; HYDROGEN BOND; HYDROPHILICITY; LIPOPHILICITY; MEAN RESIDENCE TIME; MUCOADHESION; MUCUS; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PERMEABILITY BARRIER; STATIC ELECTRICITY; SURFACE PROPERTY;

EID: 84876813203     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2012.029     Document Type: Article

References (19)

1. Amsden B. 1998. Solute Diffusion within Hydrogels. Mechanisms and Models. Macromolecules, 31(23), 8382-95.
2. Amsden B. 1999. An Obstruction-Scaling Model for Diffusion in Homogeneous Hydrogels. Macromolecules, 32(3), 874-9.
3. Brayshaw DJ, Berry M and McMaster TJ. 2003. Optimisation of sample preparation methods for air imaging of ocular mucins by AFM. Ultramicroscopy, 97(1-4), 289-96.
4. Broughton-Head VJ, Smith JR, Shur J and Shute JK. 2007. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Pulm Pharmacol Ther, 20(6), 708-17.
5. Cone RA. 2009. Barrier properties of mucus. Adv Drug Deliv Rev, 61(2), 75-85.
6. Ensign LM, Schneider C, Suk JS, Cone R and Hanes J. 2012. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv Mater, 24(28), 3887-94.
7. Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI, et al. 1996. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med, 184(3), 1045-59.
8. Jain S, Uchegbu IF, Betageri G and Pastorin G. 2011. Nanotechnology in advanced drug delivery. J Drug Deliv, 2011, 2011, 343082.
9. Kas HS. 1997. Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul, 14(6), 689-711.
10. Knowles MR and Boucher RC. 2002. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest, 109(5), 571-7.
11. Lai SK, O'Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, et al. 2007. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A, 104(5), 1482-7.
12. Lai SK, Wang YY and Hanes J. 2009. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev, 61(2), 158-71.
13. Lele BS and Hoffman AS. 2000. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. J Control Release, 69(2), 237-48.
14. Mantle M, Basaraba L, Peacock SC and Gall DG. 1989. Binding of Yersinia enterocolitica to rabbit intestinal brush border membranes, mucus, and mucin. Infect Immun, 57(11), 3292-9.
15. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR and Cone RA. 2011. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J, 81(4), 1930-7.
16. Ponchel G and Irache J. 1998. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev, 34(2-3), 191-219.
17. Saltzman WM, Radomsky ML, Whaley KJ and Cone RA. 1994. Antibody diffusion in human cervical mucus. Biophys J, 66(2 Pt 1), 508-15.
18. Wang YY, Lai SK, So C, Schneider C, Cone R and Hanes J. 2011. Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure. PLoS One, 6(6), e21547.
19. Woodley J. 2001. Bioadhesion: new possibilities for drug administration? Clin Pharmacokinet, 40(2), 77-84.